CLOSING BELL | | The market bounced Monday after Friday’s chip wreck, but the repair job was a lot cleaner in AI than anywhere else. | Semis led the comeback after the Philly Semiconductor index posted its worst one-day drop since 2020 on Friday. Breadth was still ugly, with only 3 of 11 sectors green, so this was not a heroic all-clear. It was a tech rebound with a limp. | The day started with weekend attack runs between Iran and Israel, the president begging the two adversaries to stop hurling missiles at one another. The market digested the 100th day of the war on Sunday, 100 days of airstrikes and ceasefires, and nearly 100 days of closed traffic through the Strait of Hormuz. | The world is waiting with bated breath for SpaceX to launch for trading on the Nasdaq, likely pricing this Friday. Users on Stocks think it will become the most valuable company in the world by market cap, if only briefly. OpenAI filed confidentially Monday for their own public offering, and Anthropic is also launching soon after filing right as June began: it's going to be a hot week for AI stocks. Or I guess, space stocks. | Stocktwits chatter clustered around Applied Digital after its 210 MW lease pushed the AI data-center backlog story back to the front page. | | Today's Briefing: | After the Bell: Apple’s Siri AI reset sold off anyway, while Applied Digital added another hyperscaler lease Stocks: FuelCell got punished for messy earnings, and GLP-1 traders split between Novo weakness and challenger optionality Pops and Drops & More
|
| |
| | |
|
| | | | AFTER THE BELL
Siri's Sell-the-News Moment |  | From Apple Newsroom |
| Apple finally gave Wall Street the Siri AI reset it had been waiting for at WWDC on Monday, and the stock still faded from a record high. The keynote had the pieces, but not enough near-term iPhone upgrade juice to keep buyers chasing. Apple originally showed off Apple Intelligence years ago, but only recently made moves with Google to build AI chat based on Gemini. | The RIP: $AAPL ( ▼ 1.89% ) closed -1.89% at $301.54. Shares opened at $308.74, hit $317.40, volume was 77.6M shares, and after-hours traded -0.46% at $300.15. | Apple showed a dedicated Siri app, more conversational answers, personal-context tools, AI-powered password actions, and cloud models running on Nvidia GPUs through Google. The new tech looks promising, a long overdue integration right in iPhones, but the rollout is still a work in progress. Apple said the new tech should come out this fall, alongside other hardware products. We’ve heard that before, haven’t we? | That helps the “Apple has an AI plan” case, but it also feeds the bear case that Cupertino is renting frontier AI while investors still wait for proof it can sell more devices. Community is bearish, message volume is normal across ~981k watchers. | @TruthOrTruce said: "$AAPL how is this down? Apple finally integrated AI in Siri." (post) @PhotonicDigger said: "$AAPL Classic sell the news reaction today as Apple rolls out its Siri AI features." (post)
| Jump into $AAPL: reset or rerate → | Applied Digital Leases Up | Applied Digital, the AI data center builder, jumped after hours when it announced it signed another hyperscaler lease Monday, giving investors a fresh reason to treat its AI Factory model as backlog instead of just a big-power dream. | The RIP: $APLD ( ▲ 3.34% ) rose +8.3% after hours; Delta Forge 2 lease covers 210 MW; the base term is 15 years; contracted revenue is $5.2B; renewal options lift potential revenue to $12.7B over 30 years; initial operations are expected in Q1 2028. The firm said it was building this new center in a southern state, part of a total $36B in base term lease revenue. | The contract pushes Applied Digital’s five-campus portfolio to 1.4 GW of critical IT load, but the hard part is still ahead. Holders are betting the company can finance, build, and energize these campuses fast enough for backlog to become cash flow, not just a press-release scoreboard.
The community is bearish, but message volume is low across ~43.7k watchers. | Trending posts: | @KavaStocks said: "$APLD The stocks have moved on the backlog. They have not yet moved on the income statement." (post) @LetRride said: "$APLD You would think a $5.2B contract would get you more than 8%." (post)
| Make your case in $APLD: backlog or buildout → |
STOCKS
FuelCell Runs Out Of Juice | $FCEL ( ▼ 10.56% ) got clipped after morning earnings came up short, the stock dropping -10.6%as traders looked past the AI power story and focused on the messier parts of the quarter. | The RIP: FuelCell reported Q2 revenue of $35.6M, down 5% year over year, while net loss widened to $77.6M. The big drag was a $42.6M non-cash impairment tied to its Groton project, which gave bears an easy reason to fade the move. Bulls still had something to chew on, though: the company said its sales pipeline hit 4 GW, up 267% from Q1, with data center demand driving the pitch. | That makes $FCEL a clean “promise vs. proof” trade. The AI data center power story is real enough to keep retail watching the stock, but the market wants signed contracts, not just proposals, especially from a company still burning cash and leaning on capital raises. | Community: Stocks sentiment was bearish, with 34% bullish and 66% bearish across roughly 143k watchers. Bulls called the Groton hit a one-time kitchen-sink charge and pointed to the 4 GW pipeline, while bears argued the AI hype needs actual deals before the stock deserves another run. | GLP-1 Crowd Picks Sides | The obesity-drug trade split Monday after Novo Nordisk announced just how many patients were using its oral weightloss pill at an ADA conference. The stock fell back despite the milestone, investors selling the news, while Viking Therapeutics and Structure Therapeutics kept drawing challenger attention from traders hunting the next oral pill or tolerability winner. | The RIP: $NVO ( ▼ 4.52% ) fell -4.4%; Wegovy pill topped 3M prescriptions; $GPCR ( ▲ 0.51% ) rose +0.5%; aleniglipron showed up to 11.3% placebo-adjusted weight loss at 36 weeks; AstraZeneca’s elecoglipron showed 11.8% weight loss at 36 weeks. | The retail read was less “all GLP-1s up” and more scoreboard trading. Novo still has the commercial machine, but the stock is trading like investors need proof that CagriSema, oral Wegovy, and pricing can defend share against Lilly and the next wave of small-molecule challengers. | Stocks traders leaned into optionality. The Viking stream focused on whether VK2735’s Phase 3 data can match or beat Lilly and Novo on efficacy and tolerability, while Structure bulls framed aleniglipron as one of the cleaner oral obesity-pill shots after its Phase 2b publication. | Watch $VKTX: clean readout or crowded trade → |
| |
| | |
| | | | | TRENDING ON STOCKTWITS
Pops & Drops | $TNGX ( ▲ 52.97% ) Tango : soared +51% after early pancreatic cancer combo data wowed biotech bulls $INTC ( ▲ 11.19% ) Intel: surged +11%after Google foundry order reports hit $TCNNF ( ▲ 10.73% ) Trulieve : popped +11% after NYSE uplisting plans lit up cannabis $MU ( ▲ 9.87% ) Micron: climbed +10%after AI memory momentum pulled buyers back $MRVL ( ▲ 9.63% ) Marvell: ripped +10%after S&P 500 inclusion triggered index buying $KLAC ( ▲ 9.27% ) KLA: surged +9% after stock-split buzz lifted chip-equipment leaders $AMAT ( ▲ 8.64% ) Applied Materials:climbed +9% after AI equipment demand kept semicap bulls buying $QCOM ( ▲ 0.85% ) Qualcomm :jumped +6% after Nvidia-led Computex pressure sparked dip buying $CTRA ( ▼ 8.46% ) Coterra: tumbled -8%after Devon merger closing pressured energy holders
| | |
|
|
|
|
|
|
|
